578 related articles for article (PubMed ID: 28818408)
1. Serial Assessment of Natriuretic Peptides in Patients Undergoing Interventional Closure of the Left Atrial Appendage.
Luani B; Rauwolf T; Groscheck T; Tanev I; Herold J; Isermann B; Schmeisser A; Braun-Dullaeus RC
Heart Lung Circ; 2018 Jul; 27(7):828-834. PubMed ID: 28818408
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous Closure of Left Atrial Appendage affects Mid-Term Release of MR-proANP.
Behnes M; Sartorius B; Wenke A; Lang S; Hoffmann U; Fastner C; Borggrefe M; Roth T; Triebel J; Bertsch T; Akin I
Sci Rep; 2017 Aug; 7(1):9028. PubMed ID: 28831085
[TBL] [Abstract][Full Text] [Related]
3. Left atrial enlargement and clinical considerations in patients with or without a residual interatrial shunt after closure of the left atrial appendage with the WATCHMAN™-device.
Luani B; Groscheck T; Genz C; Tanev I; Rauwolf T; Herold J; Medunjanin S; Schmeisser A; Braun-Dullaeus RC
BMC Cardiovasc Disord; 2017 Dec; 17(1):294. PubMed ID: 29233088
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
5. Influence of Left Atrial Appendage Amputation on Natriuretic Peptides-A Randomized Controlled Trial.
Grieshaber P; Arneth B; Steinsberger F; Niemann B; Oswald I; Renz H; Böning A
Thorac Cardiovasc Surg; 2021 Mar; 69(2):117-123. PubMed ID: 30929250
[TBL] [Abstract][Full Text] [Related]
6. Atrial and Brain Natriuretic Peptide Secretion After Percutaneous Closure of the Left Atrial Appendage With the Watchman Device.
Majunke N; Sandri M; Adams V; Daehnert I; Mangner N; Schuler G; Moebius-Winkler S
J Invasive Cardiol; 2015 Oct; 27(10):448-52. PubMed ID: 25999139
[TBL] [Abstract][Full Text] [Related]
7. Brain natriuretic peptide levels variation after left atrial appendage occlusion.
Cruz-Gonzalez I; Palazuelos Molinero J; Valenzuela M; Rada I; Perez-Rivera JA; Arribas Jimenez A; Gabella T; Prieto AB; Martín Polo J; Sánchez PL
Catheter Cardiovasc Interv; 2016 Jan; 87(1):E39-43. PubMed ID: 26033157
[TBL] [Abstract][Full Text] [Related]
8. Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
Bégué C; Mörner S; Brito D; Hengstenberg C; Cleland JGF; Arbustini E; Galve E; Wichter T; Richter A; Golmard JL; Bernard M; Dubourg O; Komajda M; Charron P; Isnard R
Heart; 2020 Feb; 106(3):196-202. PubMed ID: 31350276
[TBL] [Abstract][Full Text] [Related]
9. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
10. Independent effect of atrial fibrillation on natriuretic peptide release.
Sramko M; Wichterle D; Melenovsky V; Franekova J; Clemens M; Fukunaga M; Kautzner J
Clin Res Cardiol; 2019 Feb; 108(2):142-149. PubMed ID: 30051184
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
[No Abstract] [Full Text] [Related]
12. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
[TBL] [Abstract][Full Text] [Related]
13. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
[TBL] [Abstract][Full Text] [Related]
14. Association between the N-terminal plasma brain natriuretic peptide levels or elevated left ventricular filling pressure and thromboembolic risk in patients with non-valvular atrial fibrillation.
Yu GI; Cho KI; Kim HS; Heo JH; Cha TJ
J Cardiol; 2016 Aug; 68(2):110-6. PubMed ID: 26775889
[TBL] [Abstract][Full Text] [Related]
15. The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.
Kube J; Ebner N; Jankowska EA; Rozentryt P; Cicoira M; Filippatos GS; Ponikowski P; Doehner W; Anker SD; von Haehling S
Int J Cardiol; 2016 Sep; 219():84-91. PubMed ID: 27288971
[TBL] [Abstract][Full Text] [Related]
16. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.
Letzner J; Berger F; Schwabe S; Benzing J; Morgenthaler NG; Bucher HU; Bührer C; Arlettaz R; Wellmann S
Neonatology; 2012; 101(2):116-24. PubMed ID: 21952518
[TBL] [Abstract][Full Text] [Related]
17. Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study.
Charitakis E; Walfridsson H; Alehagen U
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633393
[TBL] [Abstract][Full Text] [Related]
18. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A
Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
[TBL] [Abstract][Full Text] [Related]
20. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
